CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
antibiofilm surfactant wound gel (ABWG)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04648631
NCT04648631N/ACompleted
CompareCT.gov

The Microbiome of Hidradenitis Suppurativa (HS) Tunneling Wounds

University of Miami·interventional·Posted Dec 1, 2020·Updated Apr 2, 2024

In Brief

A clinical study evaluating antibiofilm surfactant wound gel (ABWG) for Hidradenitis Suppurativa. Completed, enrolled 15 participants across 1 site.

Detailed Summary

The purpose of this study is to look at the change in the microbiome (bacterial composition) of an HS tunneling wound and examine if treatment with an antibiofilm surfactant wound gel (ABWG) (a topical medication that will fight bacteria attached to the surface of those tunnels) changes the bacterial composition of the wounds.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHidradenitis Suppurativa
CountriesUnited States
CollaboratorsNext Science LLC

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedDec 1, 2020
Enrollment StartFeb 26, 2021
Primary CompletionJul 28, 2022
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 5.6 years ago

Interventions

antibiofilm surfactant wound gel (ABWG)device

ABWG is a hydro-gel applied topically using a tongue depressor